Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina (ILMN) Soars 3.4%: Is Further Upside Left in the Stock?
10:06am, Monday, 24'th Jul 2023
Illumina (ILMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
These 13 S&P 500 stocks stand out for expected growth through 2025
10:42am, Thursday, 20'th Jul 2023
As the 2023 stock-market rally continues, this is a good time to look further ahead to see which companies are expected to show the highest growth rates through 2025.
Shady Business: 3 Well-Known Stocks That Deserve to Be on Your Blacklist
04:27pm, Monday, 17'th Jul 2023
Bank of America (NYSE: BAC ) is one of the country's largest banks. It's also one of America's most well-known stocks thanks to Warren Buffett's 13% ownership stake.
Illumina receives record US$476M fine from EU for closing Grail deal without approval
10:02am, Wednesday, 12'th Jul 2023
Illumina, Inc, a genetic testing company, was fined a record 432-million-euro (US$476 million) by the European Union (EU) on Wednesday for closing its takeover of cancer test maker Grail before secur
EU Fines Illumina Record $476 Million for Closing Grail Deal Without Approval
09:40am, Wednesday, 12'th Jul 2023
The European Commission fined biotech firm Illumina 432 million euros ($476 million) for closing its acquisition of Grail without the commission's approval, in the Commission's largest merger regulati
Illumina to Appeal EU Fine for Closing Grail Acquisition Early
07:56am, Wednesday, 12'th Jul 2023
The European Commission says the gene-sequencing company completed its acquisition of Grail, a cancer test developer, before receiving the appropriate approvals.
Illumina Fined $476 Million For Acquiring Cancer Test Maker Grail Without EU Approval
07:04am, Wednesday, 12'th Jul 2023
The record antitrust fine from the EU comes months after the FTC ordered the company to divest its $7.1 billion acquisition of Grail.
EU regulators fine Illumina $476 mln for closing Grail deal without green light
06:12am, Wednesday, 12'th Jul 2023
EU antitrust regualators on Wednesday fined Illumina a record 432 million euros ($476.19 million) for closing its takeover of Grail before securing EU antitrust approval.
Illumina hit with record fine for closing Grail deal without EU regulatory approval
06:04am, Wednesday, 12'th Jul 2023
The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice.
Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early
06:04am, Wednesday, 12'th Jul 2023
The European Union's antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency was still reviewing it.
LGND or ILMN: Which Is the Better Value Stock Right Now?
01:17pm, Tuesday, 11'th Jul 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand Pharmaceuticals (LGND) or Illumina (ILMN). But which of these two stocks is more attra
Will Illumina Stock Rebound After A 65% Decline In The Ongoing Inflation Shock?
09:00am, Friday, 07'th Jul 2023
While this may not happen anytime soon, ILMN stock looks attractive from a valuation perspective and can see higher levels.
Illumina to lay off workers as part of cost cuts amid Icahn fight
05:16pm, Monday, 26'th Jun 2023
Illumina Inc. ILMN, -4.85% disclosed Monday that it has begun laying off workers, as the DNA-sequencing company looks to cut costs amid a withering fight with activist investor Carl Icahn. In a filing
CEO Shuffle: 7 Stocks That Could Gain Momentum From New Leadership
02:17pm, Sunday, 25'th Jun 2023
New CEOs can breathe new life into a company by launching new initiatives, hiring more effective managers, and/or entering new markets. One great example is General Electric.
LGND vs. ILMN: Which Stock Is the Better Value Option?
01:24pm, Friday, 23'rd Jun 2023
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Ligand Pharmaceuticals (LGND) and Illumina (ILMN). But which of these two stocks is more
